Search Bidwells

Search Bidwells

Talk to the people behind the exciting things we do at Bidwells.

Our people

    Sorry, there were no results for your search. Please try again loader

      Cell & Gene Therapy Report

      Our latest research report from our Life Sciences 2030 series explores the fastest growing area within the therapeutics market, Cell & Gene Therapy.

      06 Mar 2023 2 minute read LIFE SCIENCE 2030


      Cell and Gene therapies (CGT) are currently tipping the scales as the fastest growing area within the therapeutics market.

      While the property sector has quickly absorbed and understood the broad spectrum of requirements of companies working across the various facets of CGT, it is clear demand will evolve and change over the coming years.

      This report explores the evolution of CGT, market growth value, challenges, local considerations and real estate demands. 

      Download the report

      Thank you.

      You can now download a copy of our Cell & Gene Therapy Paper.

      Sign me up for future updates
      Yes No
      Science and Technology

      Privacy notice


      Get in touch

      Tahrima Rahim, Research Analyst at Ironstone Asset Management

      LS REIT.jpg This paper has been written jointly with Tahrima Rahim, she is a Research Analyst at Ironstone Asset Management, the investment adviser to Life Science REIT.

      Our Expertise

      Related Services

      Science & Technology

      Life Sciences Budget blog

      Credits: Bio-Innovation Centre, TusPark, Cambridge Science Park; Babraham Research Campus; Sherard Building, Oxford Science Park

      Life Science Abstract Background2

      We are witnessing an evolution of the life science sector both in the UK and internationally. Not only is the sector expanding rapidly but scientific developments are facilitating new techniques and product outputs.

      Download our report

      Stay in the loop

      Sign up to receive personalised property alerts, and to hear the latest news, insight and advice from our experts

      Keep me informed

      Share this paper